James Edgemond, CFO AND TREASURER at UNITED THERAPEUTICS Corp (UTHR), sold 8,750 shares at $534.06 ($4.7M) on 2026-06-22, disclosed to the SEC on 2026-06-23.
Scheduled sale ($4.7M) by CFO AND TREASURER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $534.06 | 164 | $88K | 1.9% |
| 2 | $534.98 | 865 | $463K | 9.8% |
| 3 | $536.05 | 1,091 | $585K | 12.4% |
| 4 | $537.18 | 840 | $451K | 9.6% |
| 5 | $538.23 | 2,266 | $1.2M | 25.9% |
| 6 | $539.13 | 1,994 |
| $1.1M |
| 22.8% |
| 7 | $539.83 | 280 | $151K | 3.2% |
| 8 | $541.25 | 1,250 | $677K | 14.4% |
| Total | $538.15 avg | 8,750 | $4.7M | 100% |
| Filing → |
| UTHR | SELL | 2026-06-12 | $5.5M | — | Filing → |
| UTHR | SELL | 2026-06-09 | $5.5M | — | Filing → |
| UTHR | SELL | 2026-06-05 | $5.5M | — | Filing → |